How to de-risk your LNP-mRNA drug development?

To help you detect hEPO in LNPs-mRNA drug development and clinical diagnostics, ACROBiosystems has developed the ClinMax™ Human Erythropoietin (EPO) ELISA Kit (Catalog Number: CEA-C027) based on its immunological analysis platform. This kit offers enhanced sensitivity, faster detection speed, and other features, enabling it to meet the detection needs of various complex samples and accelerate the process of your research.

EPO in LNP-mRNA

In LNP-mRNA drug development, optimization of mRNA molecules and efficient in vivo delivery are important but challenging. Quantifying EPO in cell supernatant and serum by ELISA technology can effectively evaluate the pharmacology and pharmacodynamics of modified mRNA based on lipid nanoparticles (LNPs).

EPO in Anemia

EPO is part of a class of substances called Erythropoiesis-Stimulating Agents (ESAs). In a clinical setting, assays to measure EPO levels in serum, plasma and other biological fluids are important tools for diagnostic purposes and for research into the role of EPO in various forms of anemia and polycythemia.

EPO ELISA Kit (CEA-C027)

Analyte	EPO
Format	96T
Reactivity	Human
Sensitivity	<0.67 mIU/mL
Standard Curve Range	0.87 mlU/mL-212 mlU/mL
Assay Time	2 hr 45min
Suitable Sample Type	For the quantitative determination of human EPO in serum, plasma, and cell supernatant.
Sample volume	50 μL

Request for a free sample！